Fingerprint
Dive into the research topics of 'Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors
The COVID Moonshot consortium, Alpha A. Lee, Hagit Achdout, Anthony Aimon, Dominic S. Alonzi, Robert Arbon, Jasmin C. Aschenbrenner, Blake H. Balcomb, Elad Bar-David, Haim Barr, Amir Ben-Shmuel, James Bennett, Vitaliy A. Bilenko, Melissa L. Boby, Bruce Borden, Pascale Boulet, Gregory R. Bowman, Lennart Brewitz, Juliane Brun, Sarma Bvnbs
- PostEra Inc.
- Kyiv National Taras Shevchenko University
- Israel Institute for Biological Research
- Diamond Light Source
- Research Complex at Harwell
- University of Oxford
- Memorial Sloan-Kettering Cancer Center
- Weizmann Institute of Science
- Enamine Ltd
- Folding@Home Consortium
- Drugs for Neglected Diseases initiative (DNDi)
- University of Pennsylvania
- Sai Life Sciences
- UCB S.A.
- Takeda Pharmaceutical Company
- Argonne National Laboratory
- Cauldron Development Oy
- Cambridge Crystallographic Data Centre
- University of Milan
- Life Compass Consulting Ltd
- University of Cambridge
- KU Leuven
- Datryllic LLC
- Informatics Matters Ltd.
- Stanford University
- Northeastern University
- Thames Pharma Partners LLC
- Temple University
Research output: Contribution to journal › Article › peer-review
49
Scopus
citations